primaquine sr Search Results


93
Chem Impex International xylazine xyl
Xylazine Xyl, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/xylazine xyl/product/Chem Impex International
Average 93 stars, based on 1 article reviews
xylazine xyl - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

95
Chem Impex International erythromycin
Erythromycin, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erythromycin/product/Chem Impex International
Average 95 stars, based on 1 article reviews
erythromycin - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

96
Chem Impex International imipenem monohydrate
Imipenem Monohydrate, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/imipenem monohydrate/product/Chem Impex International
Average 96 stars, based on 1 article reviews
imipenem monohydrate - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

90
Ipca Laboratories primaquine sr
Disposition of study participants. PT: <t>primaquine</t> therapy, CT: chloroquine therapy, and MP: malarial parasite.
Primaquine Sr, supplied by Ipca Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primaquine sr/product/Ipca Laboratories
Average 90 stars, based on 1 article reviews
primaquine sr - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier




Image Search Results


Disposition of study participants. PT: primaquine therapy, CT: chloroquine therapy, and MP: malarial parasite.

Journal: Malaria Research and Treatment

Article Title: Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

doi: 10.1155/2015/579864

Figure Lengend Snippet: Disposition of study participants. PT: primaquine therapy, CT: chloroquine therapy, and MP: malarial parasite.

Article Snippet: The concept of developing primaquine SR 15 mg (manufactured by Ipca Labortories Ltd., India) and primaquine SR 30 mg (manufactured by Ipca Labortories Ltd., India) formulations was based on maintaining adequate therapeutic concentration over 24 hours and reducing the treatment duration from 14 days to seven days for better patient compliance.

Techniques:

Kaplan-Meier estimates of cumulative risk of relapse. P 15 mg: conventional primaquine 15 mg, PSR 15 mg: primaquine sustained release 15 mg, and PSR 30 mg: primaquine sustained release 30 mg. Numbers written over the line are patients still undergoing follow-up. Differences in cumulative risk of relapse are statistically insignificant; p = 0.16 for test of equality over strata using Log rank test.

Journal: Malaria Research and Treatment

Article Title: Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

doi: 10.1155/2015/579864

Figure Lengend Snippet: Kaplan-Meier estimates of cumulative risk of relapse. P 15 mg: conventional primaquine 15 mg, PSR 15 mg: primaquine sustained release 15 mg, and PSR 30 mg: primaquine sustained release 30 mg. Numbers written over the line are patients still undergoing follow-up. Differences in cumulative risk of relapse are statistically insignificant; p = 0.16 for test of equality over strata using Log rank test.

Article Snippet: The concept of developing primaquine SR 15 mg (manufactured by Ipca Labortories Ltd., India) and primaquine SR 30 mg (manufactured by Ipca Labortories Ltd., India) formulations was based on maintaining adequate therapeutic concentration over 24 hours and reducing the treatment duration from 14 days to seven days for better patient compliance.

Techniques:

Numbers of AEs reported during chloroquine therapy and  primaquine  therapy.

Journal: Malaria Research and Treatment

Article Title: Sustained Release Formulation of Primaquine for Prevention of Relapse of Plasmodium vivax Malaria: A Randomized, Double-Blind, Comparative, Multicentric Study

doi: 10.1155/2015/579864

Figure Lengend Snippet: Numbers of AEs reported during chloroquine therapy and primaquine therapy.

Article Snippet: The concept of developing primaquine SR 15 mg (manufactured by Ipca Labortories Ltd., India) and primaquine SR 30 mg (manufactured by Ipca Labortories Ltd., India) formulations was based on maintaining adequate therapeutic concentration over 24 hours and reducing the treatment duration from 14 days to seven days for better patient compliance.

Techniques: